HOME >> BIOLOGY >> NEWS
Molecule that destroys bone also protects it, new research shows

BUFFALO, N.Y. -- An immune system component that is a primary cause of bone destruction and inflammation in autoimmune diseases such as rheumatoid arthritis actually protects bone in the oral cavity from infectious pathogens that play a major role in periodontal disease in humans, research at the University at Buffalo has shown.

The component, IL-17, was recognized only in the past 18 months to be a primary cause of bone destruction and inflammation in autoimmune diseases. Therapies that target IL-17 or its cellular receptor currently are being developed.

However, a UB molecular biologist has discovered that, in contrast to its action in rheumatoid arthritis(RA), IL-17 actually protects bone in the oral cavity from infectious pathogens such as Porphyromonas gingivalis, a bacterium that plays a major role in most periodontal disease in humans.

The research findings appear in the current (May) issue of the journal Blood.

Sarah L. Gaffen, Ph.D., associate professor of oral biology in the UB School of Dental Medicine and associate professor of microbiology and immunology in the UB School of Medicine and Biomedical Sciences, is senior author. Jeffrey J. Yu, a medical student and doctoral candidate who is a researcher working in Gaffens lab, is first author.

Gaffen and colleagues conducted the research in mice bred to have no receptors for IL-17. Other researchers had shown previously, using rats and mice as animal models, that blocking the receptor for IL-17 could be an effective therapy for RA and possibly for other autoimmune diseases such as multiple sclerosis, colitis, psoriasis and lupus.

The effects of an IL-17 deficiency in periodontal disease, however, were unknown, so Gaffens lab set out to investigate.

"I predicted these mice without the IL-17 receptor were going to be protected from periodontal bone loss, just like theyre protected from arthritic bone loss," Gaffen said. "In fact, we got the opposite
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
8-May-2007


Page: 1 2 3

Related biology news :

1. Molecule blocks gene, sheds light on liver cancer
2. Howard C. Berg honored with Outstanding Investigator in Single Molecule Biology Award
3. Molecule discovered to be key to pain sensitivity
4. Molecules in blood foretell development of preeclampsia
5. Molecule by molecule, new assay shows real-time gene activity
6. Molecule does more than slice and dice RNA
7. Molecule links Down syndrome to Alzheimers
8. Molecule crucial for processing non-coding RNA identified
9. Molecule on immune cells linked to sexual transmission of HIV
10. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
11. Molecule that helps DNA replicate may make good target for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... PA’s, RN’s, LPN’s, MA's and Administrative staff. , This full day course is ... biologics. The course will expose your staff to regenerative medicine procedures and processing ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek ... and to accelerate Lifecycle’s continued growth and expansion. , With over 20 ...
Breaking Biology News(10 mins):
(Date:7/31/2018)... ... 2018 , ... Leading regenerative veterinary medicine company, VetStem Biopharma, ... adipose tissue-derived stem cells to treat or prevent inflammation at the site of ... specifically, VetStem has been issued similar patents that cover the United States as ...
(Date:7/26/2018)... ... July 26, 2018 , ... Ariadne ... of a biofield energy treated nutraceutical to improve anti-inflammatory and immune function responses. ... assessed in the preclinical research, were significantly reduced. Results are as follows:, ...
(Date:7/25/2018)... ... July 25, 2018 , ... ... Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including ... podiatric medical education and clinical experience. Their students receive comprehensive academic training ...
(Date:7/24/2018)... ... 2018 , ... R3 Stem Cell is now offering regenerative therapies for COPD ... Double Board Certified providers, with outcomes significantly improving patient quality of life. , Traditional ... nothing to help repair and regenerate damaged lung tissues. Stem cell therapy for ...
Breaking Biology Technology:
Cached News: